publication venue for
- Peripheral neuropathy associated with ipilimumab: a report of 2 cases. 2015
- Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience.. 45. 2022
- Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint Inhibitors.. 44. 2021
- Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia.. 44. 2021
- Pretreatment eosinophil counts in patients with advanced or metastatic urothelial carcinoma treated with anti-PD-1/PD-L1 checkpoint inhibitors. 44:248-253. 2021
- Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.. 42. 2019
- Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program.. 40. 2017
- Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor.. 38. 2015
- CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893.. 33. 2010
- High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction.. 32. 2009
- Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy.. 32. 2009
- Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.. 31. 2008
- Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma.. 30. 2007
- Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications.. 30. 2007
- Interaction of Pneumocystis carinii with dendritic cells and resulting host responses to P. carinii.. 30. 2007
- Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901.. 29. 2006
- Intratumoral expression of macrophage-derived chemokine induces CD4+ T cell-independent antitumor immunity in mice.. 26. 2003
- Restoration of alloreactivity of melanoma by transduction with B7.1.. 23. 2000
- Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats.. 22. 1999
- Cancer and inflammation: promise for biologic therapy. 2010